Explore jobs
Find specific jobs
Explore careers
Explore professions
Best companies
Explore companies
MacroGenics revenue
MacroGenics's revenue is $150.0 million.
What is MacroGenics's revenue?
- MacroGenics's revenue growth from 2012 to 2024 is 134.95%.
- MacroGenics has 307 employees, and the revenue per employee ratio is $488,475.
- MacroGenics's peak quarterly revenue was $152.4M in 2017(q4).
- MacroGenics peak revenue was $157.7M in 2017.
- MacroGenics annual revenue for 2023 was 58.7M, -61.33% growth from 2022.
- MacroGenics annual revenue for 2024 was 150.0M, 155.26% growth from 2023.
On this page
Zippia finds jobs where you're a top candidate and applies on your behalf.
MacroGenics historical revenue
MacroGenics's peak revenue was $157.7M in 2017. The peak quarterly revenue was $152.4M in 2017(q4).
MacroGenics's revenue increased from $63.8m in 2012 to $150.0M currently. That's a 134.95% change in annual revenue.
MacroGenics annual revenue
MacroGenics annual revenue over time
| Fiscal year / year | MacroGenics revenue |
|---|---|
| 2012 | $63.8M |
| 2013 | $58.0M |
| 2014 | $47.8M |
| 2015 | $100.9M |
| 2016 | $91.9M |
| 2017 | $157.7M |
| 2018 | $60.1M |
| 2019 | $64.2M |
| 2020 | $104.9M |
| 2021 | $77.4M |
| 2022 | $151.9M |
| 2023 | $58.7M |
| 2024 | $150.0M |
Rate MacroGenics' financial transparency
MacroGenics annual growth
MacroGenics saw the greatest revenue growth in 2015, when revenue increased by 111.0%.
MacroGenics had the lowest revenue growth in 2018, when revenue changed by -61.89%.
MacroGenics annual growth rate over time
| Year | MacroGenics growth |
|---|---|
| 2013 | -9%↓ |
| 2014 | -18%↓ |
| 2015 | 111%↑ |
| 2016 | -9%↓ |
| 2017 | 72%↑ |
| 2018 | -62%↓ |
| 2019 | 7%↑ |
| 2020 | 63%↑ |
| 2021 | -26%↓ |
| 2022 | 96%↑ |
| 2023 | -61%↓ |
| 2024 | 155%↑ |
MacroGenics quarterly revenue over time
- Q1
- Q2
- Q3
- Q4
MacroGenics quarterly growth rate over time
| Year | Q1 | Q2 | Q3 | Q4 |
|---|---|---|---|---|
| 2013 | - | - | $20.2M | $16.0M |
| 2014 | $14.7M | $9.2M | $18.4M | $5.9M |
| 2015 | $71.3M | $5.6M | $14.7M | $9.4M |
| 2016 | $1.9M | $80.7M | $2.0M | $9.5M |
| 2017 | $1.3M | $1.1M | $1.1M | $152.4M |
| 2018 | $4.7M | $18.8M | $20.8M | $15.0M |
| 2019 | $9.7M | $10.0M | $18.7M | $25.2M |
| 2020 | $13.0M | $15.6M | $18.3M | $52.7M |
| 2021 | $16.0M | $30.7M | $15.8M | $12.4M |
| 2022 | $11.1M | $26.0M | $41.7M | $73.1M |
| 2023 | $24.5M | $13.1M | $10.4M | $9.2M |
| 2024 | $9.1M | $10.8M | $110.7M | $19.4M |
MacroGenics jobs nearby
Do you work at MacroGenics?
Is MacroGenics transparent about its revenue structure?
MacroGenics financial information
| Industry | Software & Services |
| Company Type | Public |
| Employees Number | 307 |
| Date Founded | 2000 |
| Headquarters | Rockville, Maryland |
| Number of Locations | 1 |
| Revenue | $150.0M |
| Net Income | -$119,758,000 |
| Gross Proft | $137.7M (2024) |
| PE Ratio | -7.21 |
| Tax Rate | -0.0% |
| Market Capitalization | $483.0M |
| Total Assets | $280,468,000 |
| Ticker | MGNX |
MacroGenics jobs you might like
MacroGenics financing
MacroGenics received early financing of $13.5M on 2001-09-25.
| Series | Round size | Date |
|---|---|---|
| Series A | $13.5M | 09/2001 |
| Series Unknown | $12.6M | 06/2002 |
| Series A | $5M | 11/2003 |
| Series B | $30.5M | 10/2004 |
| Series C | $45M | 05/2006 |
| Series D | $12.5M | 07/2008 |
| Series D | $25M | 10/2008 |
| Grant | $9.8M | 07/2010 |
| Private Equity | $12M | 01/2011 |
MacroGenics investors
| Investors | Security type |
|---|---|
| MPM Capital | Series A |
| InterWest Partners | Series A |
| OrbiMed Advisors | Series A |
| Cogene Ventures LP | Series Unknown |
| Startech Early Ventures | Series Unknown |
| Hunt Ventures | Series Unknown |
| InterWest Partners | Series Unknown |
| MPM Capital | Series Unknown |
| OrbiMed Advisors | Series Unknown |
| Alexandria Real Estate Equities Inc. | Series Unknown |
| Emerging Technology Partners | Series B |
| Red Abbey Venture Partners | Series B |
| Cogene Ventures LP | Series B |
| Hunt Ventures | Series B |
| Mithra Ventures | Series B |
| InterWest Partners | Series B |
| MPM Capital | Series B |
| Vivo Capital | Series B |
| Alta Partners | Series B |
| OrbiMed Advisors | Series B |
| TPG | Series B |
| Caisse de dépôt et placement du Québec CDPQ | Series C |
| Red Abbey Venture Partners | Series C |
| Mithra Ventures | Series C |
| VENTURES WEST CAPITAL LTD | Series C |
| InterWest Partners | Series C |
| MPM Capital | Series C |
| Alta Partners | Series C |
| OrbiMed Advisors | Series C |
| TPG | Series C |
| RiverVest Venture Management LLC | Series C |
| Biogen Inc. | Series C |
| InterWest Partners | Series D |
| CLARUS VENTURES LLC | Series D |
| Alta Partners | Series D |
| TPG | Series D |
| Arcus Ventures | Series D |
| CIDC Consultants | Series D |
| VENTURES WEST CAPITAL LTD | Series D |
| InterWest Partners | Series D |
| Eli Lilly and Company Foundation | Series D |
| Alta Partners | Series D |
| Nextech Invest | Series D |
| Red Abbey Venture Partners | Series D |
| Innovis Investments | Series D |
| OrbiMed Advisors | Series D |
| Alexandria Real Estate Equities Inc. | Series D |
| TPG | Series D |
| Mitsubishi UFJ | Series D |
| RiverVest Venture Management LLC | Series D |
| National Institutes of Health (NIH) | Grant |
MacroGenics competitors
MacroGenics's top competitor, Alkermes, earned an annual revenue of $1.6B.
MacroGenics's smallest competitor is Syros Pharmaceuticals with revenue of $9.9M last year.
| Company name | Average salary | Revenue | Employee size | Job openings |
|---|---|---|---|---|
| Genentech | $97,473 | $166.9M | 13,638 | 541 |
| Fate Therapeutics | $52,087 | $13.6M | 104 | 17 |
| Stemline Therapeutics | $45,419 | $43.2M | 100 | - |
| Syros Pharmaceuticals | $87,102 | $9.9M | 124 | - |
| Human Genome Sciences | $70,157 | $131.0M | 1,000 | - |
| Acambis | $75,102 | $10.0M | 350 | - |
| XOMA | $52,959 | $28.5M | 11 | - |
| 454 Life Sciences | $54,620 | $19.4M | 100 | - |
| Alkermes | $76,854 | $1.6B | 1,200 | 119 |
| Dynavax Technologies | $74,118 | $277.2M | 311 | 31 |
Search for jobs
Related company revenues
Working at related companies
Related company jobs
MacroGenics highest paying jobs
Zippia gives an in-depth look into the details of MacroGenics, including salaries, political affiliations, employee data, and more, in order to inform job seekers about MacroGenics. The employee data is based on information from people who have self-reported their past or current employments at MacroGenics. The data on this page is also based on data sources collected from public and open data sources on the Internet and other locations, as well as proprietary data we licensed from other companies. Sources of data may include, but are not limited to, the BLS, company filings, estimates based on those filings, H1B filings, and other public and private datasets. While we have made attempts to ensure that the information displayed are correct, Zippia is not responsible for any errors or omissions or for the results obtained from the use of this information. None of the information on this page has been provided or approved by MacroGenics. The data presented on this page does not represent the view of MacroGenics and its employees or that of Zippia.
MacroGenics may also be known as or be related to MACROGENICS INC, MacroGenics, MacroGenics Inc, MacroGenics, Inc. and Macrogenics, Inc.